62 related articles for article (PubMed ID: 31256921)
1. Substance P and Neurokinin-1 Receptor System in Thyroid Cancer: Potential Targets for New Molecular Therapies.
Isorna I; González-Moles MÁ; Muñoz M; Esteban F
J Clin Med; 2023 Oct; 12(19):. PubMed ID: 37835053
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic and therapeutic targeting of the neurokinin-1 receptor limits neuroinflammation in a murine model of pneumococcal meningitis.
Chauhan VS; Kluttz JM; Bost KL; Marriott I
J Immunol; 2011 Jun; 186(12):7255-63. PubMed ID: 21562162
[TBL] [Abstract][Full Text] [Related]
3. The role of substance P in epilepsy and seizure disorders.
Wang XF; Ge TT; Fan J; Yang W; Cui RJ
Oncotarget; 2017 Sep; 8(44):78225-78233. PubMed ID: 29100462
[TBL] [Abstract][Full Text] [Related]
4. The impact of fibrotic diseases on global mortality from 1990 to 2019.
Mutsaers HAM; Merrild C; Nørregaard R; Plana-Ripoll O
J Transl Med; 2023 Nov; 21(1):818. PubMed ID: 37974206
[No Abstract] [Full Text] [Related]
5. Potentiation of Collagen Deposition by the Combination of Substance P with Transforming Growth Factor Beta in Rat Skin Fibroblasts.
Hilliard BA; Amin M; Popoff SN; Barbe MF
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339140
[TBL] [Abstract][Full Text] [Related]
6. Substance P promotes epidural fibrosis via induction of type 2 macrophages.
Hua F; Wang HR; Bai YF; Sun JP; Wang WS; Xu Y; Zhang MS; Liu J
Neural Regen Res; 2023 Oct; 18(10):2252-2259. PubMed ID: 37056145
[TBL] [Abstract][Full Text] [Related]
7. Targeting NK-1R attenuates renal fibrosis
Zhu E; Liu Y; Zhong M; Liu Y; Jiang X; Shu X; Li N; Guan H; Xia Y; Li J; Lan HY; Zheng Z
Front Immunol; 2023; 14():1142240. PubMed ID: 37033943
[TBL] [Abstract][Full Text] [Related]
8. Endometriosis: Cellular and Molecular Mechanisms Leading to Fibrosis.
Garcia Garcia JM; Vannuzzi V; Donati C; Bernacchioni C; Bruni P; Petraglia F
Reprod Sci; 2023 May; 30(5):1453-1461. PubMed ID: 36289173
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential for targeting Annexin A1 in fibrotic diseases.
Yan Z; Cheng X; Wang T; Hong X; Shao G; Fu C
Genes Dis; 2022 Nov; 9(6):1493-1505. PubMed ID: 36157506
[TBL] [Abstract][Full Text] [Related]
10. Substance P promotes the progression of bronchial asthma through activating the PI3K/AKT/NF-κB pathway mediated cellular inflammation and pyroptotic cell death in bronchial epithelial cells.
Li M; Zhong X; Xu WT
Cell Cycle; 2022 Oct; 21(20):2179-2191. PubMed ID: 35726575
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin Inhibition, TGF-β and EMT in Cancer.
Pallasch FB; Schumacher U
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32998363
[TBL] [Abstract][Full Text] [Related]
12. Knockout of the Tachykinin Receptor 1 in the Mdr2
Ceci L; Francis H; Zhou T; Giang T; Yang Z; Meng F; Wu N; Kennedy L; Kyritsi K; Meadows V; Wu C; Liangpunsakul S; Franchitto A; Sybenga A; Ekser B; Mancinelli R; Onori P; Gaudio E; Glaser S; Alpini G
Am J Pathol; 2020 Nov; 190(11):2251-2266. PubMed ID: 32712019
[TBL] [Abstract][Full Text] [Related]
13. Blocking CTGF/CCN2 reduces established skeletal muscle fibrosis in a rat model of overuse injury.
Barbe MF; Hilliard BA; Amin M; Harris MY; Hobson LJ; Cruz GE; Popoff SN
FASEB J; 2020 May; 34(5):6554-6569. PubMed ID: 32227398
[TBL] [Abstract][Full Text] [Related]
14. Substance P and fibrotic diseases.
Peng L; Agogo GO; Guo J; Yan M
Neuropeptides; 2019 Aug; 76():101941. PubMed ID: 31256921
[TBL] [Abstract][Full Text] [Related]
15. Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.
Wan Y; Meng F; Wu N; Zhou T; Venter J; Francis H; Kennedy L; Glaser T; Bernuzzi F; Invernizzi P; Glaser S; Huang Q; Alpini G
Hepatology; 2017 Aug; 66(2):528-541. PubMed ID: 28256736
[TBL] [Abstract][Full Text] [Related]
16. Role of substance P in the cardiovascular system.
Mistrova E; Kruzliak P; Chottova Dvorakova M
Neuropeptides; 2016 Aug; 58():41-51. PubMed ID: 26706184
[TBL] [Abstract][Full Text] [Related]
17. Human microglia and astrocytes constitutively express the neurokinin-1 receptor and functionally respond to substance P.
Burmeister AR; Johnson MB; Chauhan VS; Moerdyk-Schauwecker MJ; Young AD; Cooley ID; Martinez AN; Ramesh G; Philipp MT; Marriott I
J Neuroinflammation; 2017 Dec; 14(1):245. PubMed ID: 29237453
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
